373 related articles for article (PubMed ID: 8577769)
1. Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites.
van der Geer P; Wiley S; Gish GD; Lai VK; Stephens R; White MF; Kaplan D; Pawson T
Proc Natl Acad Sci U S A; 1996 Feb; 93(3):963-8. PubMed ID: 8577769
[TBL] [Abstract][Full Text] [Related]
2. A conserved amino-terminal Shc domain binds to phosphotyrosine motifs in activated receptors and phosphopeptides.
van der Geer P; Wiley S; Lai VK; Olivier JP; Gish GD; Stephens R; Kaplan D; Shoelson S; Pawson T
Curr Biol; 1995 Apr; 5(4):404-12. PubMed ID: 7542991
[TBL] [Abstract][Full Text] [Related]
3. Re-engineering the target specificity of the insulin receptor by modification of a PTB domain binding site.
van der Geer P; Wiley S; Pawson T
Oncogene; 1999 May; 18(20):3071-5. PubMed ID: 10340378
[TBL] [Abstract][Full Text] [Related]
4. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
[TBL] [Abstract][Full Text] [Related]
5. Shc phosphotyrosine-binding domain dominantly interacts with epidermal growth factor receptors and mediates Ras activation in intact cells.
Sakaguchi K; Okabayashi Y; Kido Y; Kimura S; Matsumura Y; Inushima K; Kasuga M
Mol Endocrinol; 1998 Apr; 12(4):536-43. PubMed ID: 9544989
[TBL] [Abstract][Full Text] [Related]
6. Shc binding to nerve growth factor receptor is mediated by the phosphotyrosine interaction domain.
Dikic I; Batzer AG; Blaikie P; Obermeier A; Ullrich A; Schlessinger J; Margolis B
J Biol Chem; 1995 Jun; 270(25):15125-9. PubMed ID: 7541035
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the phosphotyrosine-binding domain of the Drosophila Shc protein.
Li SC; Lai KM; Gish GD; Parris WE; van der Geer P; Forman-Kay J; Pawson T
J Biol Chem; 1996 Dec; 271(50):31855-62. PubMed ID: 8943228
[TBL] [Abstract][Full Text] [Related]
8. The role of the Shc phosphotyrosine interaction/phosphotyrosine binding domain and tyrosine phosphorylation sites in polyoma middle T antigen-mediated cell transformation.
Blaikie PA; Fournier E; Dilworth SM; Birnbaum D; Borg JP; Margolis B
J Biol Chem; 1997 Aug; 272(33):20671-7. PubMed ID: 9252386
[TBL] [Abstract][Full Text] [Related]
9. Identification of residues within the SHC phosphotyrosine binding/phosphotyrosine interaction domain crucial for phosphopeptide interaction.
Yajnik V; Blaikie P; Bork P; Margolis B
J Biol Chem; 1996 Jan; 271(4):1813-6. PubMed ID: 8567619
[TBL] [Abstract][Full Text] [Related]
10. Thermodynamic studies of SHC phosphotyrosine interaction domain recognition of the NPXpY motif.
Mandiyan V; O'Brien R; Zhou M; Margolis B; Lemmon MA; Sturtevant JM; Schlessinger J
J Biol Chem; 1996 Mar; 271(9):4770-5. PubMed ID: 8617744
[TBL] [Abstract][Full Text] [Related]
11. Phosphotyrosine binding domains of Shc and insulin receptor substrate 1 recognize the NPXpY motif in a thermodynamically distinct manner.
Farooq A; Plotnikova O; Zeng L; Zhou MM
J Biol Chem; 1999 Mar; 274(10):6114-21. PubMed ID: 10037694
[TBL] [Abstract][Full Text] [Related]
12. A Drosophila shc gene product is implicated in signaling by the DER receptor tyrosine kinase.
Lai KM; Olivier JP; Gish GD; Henkemeyer M; McGlade J; Pawson T
Mol Cell Biol; 1995 Sep; 15(9):4810-8. PubMed ID: 7651398
[TBL] [Abstract][Full Text] [Related]
13. Cellular effects of phosphotyrosine-binding domain inhibitors on insulin receptor signaling and trafficking.
Giorgetti-Peraldi S; Ottinger E; Wolf G; Ye B; Burke TR; Shoelson SE
Mol Cell Biol; 1997 Mar; 17(3):1180-8. PubMed ID: 9032245
[TBL] [Abstract][Full Text] [Related]
14. The Shc adaptor protein is highly phosphorylated at conserved, twin tyrosine residues (Y239/240) that mediate protein-protein interactions.
van der Geer P; Wiley S; Gish GD; Pawson T
Curr Biol; 1996 Nov; 6(11):1435-44. PubMed ID: 8939605
[TBL] [Abstract][Full Text] [Related]
15. Structure and ligand recognition of the phosphotyrosine binding domain of Shc.
Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW
Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391
[TBL] [Abstract][Full Text] [Related]
16. PTB domains of IRS-1 and Shc have distinct but overlapping binding specificities.
Wolf G; Trüb T; Ottinger E; Groninga L; Lynch A; White MF; Miyazaki M; Lee J; Shoelson SE
J Biol Chem; 1995 Nov; 270(46):27407-10. PubMed ID: 7499194
[TBL] [Abstract][Full Text] [Related]
17. Discrimination between phosphotyrosine-mediated signaling properties of conventional and neuronal Shc adapter molecules.
Nakamura T; Komiya M; Gotoh N; Koizumi S; Shibuya M; Mori N
Oncogene; 2002 Jan; 21(1):22-31. PubMed ID: 11791173
[TBL] [Abstract][Full Text] [Related]
18. The src homology 2 and phosphotyrosine binding domains of the ShcC adaptor protein function as inhibitors of mitogenic signaling by the epidermal growth factor receptor.
O'Bryan JP; Lambert QT; Der CJ
J Biol Chem; 1998 Aug; 273(32):20431-7. PubMed ID: 9685397
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the phosphotyrosine binding domain of Shc and the insulin receptor is required for Shc phosphorylation by insulin in vivo.
Isakoff SJ; Yu YP; Su YC; Blaikie P; Yajnik V; Rose E; Weidner KM; Sachs M; Margolis B; Skolnik EY
J Biol Chem; 1996 Feb; 271(8):3959-62. PubMed ID: 8626723
[TBL] [Abstract][Full Text] [Related]
20. Specificity of the PTB domain of Shc for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine.
Trüb T; Choi WE; Wolf G; Ottinger E; Chen Y; Weiss M; Shoelson SE
J Biol Chem; 1995 Aug; 270(31):18205-8. PubMed ID: 7543098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
